Biocompatibility in transfusion medicine

Transfusion Science

Volumn 17, Issue 4, 1996, Pages 481-488

  Nydegger, U ^a,b   Rieben, R ^a   Lammle B ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Regional Red Cross Blood Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BLOOD CELL; BLOOD TRANSFUSION; CHEMICAL COMPOSITION; CONFERENCE PAPER; SURFACE PROPERTY;

EID: 0347244275     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(96)90081-8     Document Type: Conference Paper

References (15)

1. Morawitz P: Die Chemie der Blutgerinnung, in Asher L, Spiro K (eds): Ergebnisse der Physiologie. Wiesbaden, JF Bergmann, 1905; p. 340.
2. Jahns G, Haeffner-Cavaillon N, Nydegger UE, Kazatchkine MD: Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits. Clin Mat 1993; 14:303-336.
3. Walsh D, Mann S: Fabrication of hollow porous shells of calcium carbonate from self-organizing media. Nature 1995; 337: 320-323.
4. Fréchet JMJ, Henmi M, Gitsov I, Adshima S, Leduc MR, Grubbs RB: Self-condensing vinyl polymerization: an approach to dendritic materials. Science 1995; 269:1080-1083.
5. Service RF: Designer tissues take hold. Science 1995; 270:230-232.
6. Paul D, Malsch G, Bossin E, et al.: Chemical modification of cellulosic membranes and their blood compatibility. Artif Organs 1990; 14:122-125.
7. Savada K, Malchesky PS, Guidubladi JM, Seuoka A, Nakayama S, Kano M, Shomoyama: In vitro serum (or plasma)-material interaction, in Agishi T, Kawamura A, Mineshima M (eds): Therapeutic Plasmapheresis (XII). Utrecht, VSP, 1993; pp. 811-814.
8. Mammen EF, Koets MH, Washington BC: Hemostasis changes during cardiopulmonary bypass surgery. Semin Thromb Hemost 1985; 11:281-292.
9. Holloway DS, Summaria L, Sandsara J, Vagher JP, Alexander JC, Carini JA: Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988; 59:62-67.
10. Walpoth BH, Amport T, Schmid R, Kipfer B, Lanz M, Spaeth P, Kurt G, Althaus U: Hemofiltration during cardiopulmonary bypass: quality assessment of hemoconcentrated blood. J Thorac Cardivasc Surgeon 1994; 42: 162-169.
11. Wegmüller E, Montandon A, Nydegger U, Descoeudres C: Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia. Int J Artif Org 1986; 9:85-92.
12. Vaudaux P, Suzuki R, Waldvogel FA, Morgenthaler JJ, Nydegger UE: Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 1984; 150: 546-553.
13. Aeschbacher B, Häberli A, Nydegger UE: Donor safety and plasma quality in automated plasmapheresis; a comparison of two filter materials. Vox Sang 1989; 57:104-111.
14. Pflugshaupt R, Kurt G: FPA-content -a criterion of quality for plasma as factor VII source. Vox Sang 1983; 45:224-232.
15. Rieben R, Korchagina EY, von Allmen E, Kremer Hovinga J, Lämmle B, Jungi TW, Bovin NV, Nydegger UE: In vitro evaluation of the efficacy and biocompatibility of new, synthetic ABO immunoabsorbents. Transplantation 1995; 60:425-430.